Boswellia

Boswellia

Pure Encapsulations4.7 (63 ratings)
Format:Capsule Quantity: 120 Capsule(s) · 120 servings
Goals
$36.50 $0.30 per serving

About this product

Each capsule supplies 400 mg of Boswellia serrata gum-resin extract. The focused one-ingredient design, substantial amount, and large supply support straightforward routine use.

Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.

Total boswellic acids, AKBA, and absorption technology are not disclosed, leaving active potency uncertain. The 120-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.

Who is it for
  • Adults seeking a large supply of standalone Boswellia
  • People who prefer supplements in capsule form
  • Users who prefer a clearly focused botanical formula
Best for
  • Simple, focused Boswellia supplementation
  • Normal inflammatory-response support
  • A routine with 120 servings per container

Pros

  • The focused one-ingredient design, substantial amount, and large supply support straightforward routine use
  • 120 servings per container
  • Single-ingredient design keeps the purpose clear

Cons

  • Total boswellic acids, AKBA, and absorption technology are not disclosed, leaving active potency uncertain.
  • Single-botanical scope does not cover cartilage structure or joint lubrication.
  • Capsule-only delivery may not suit people who avoid pills.

Warnings

  • Boswellia may add to bleeding tendency with anticoagulant or antiplatelet medicines, so this specific combination warrants medication review.
  • Count other Boswellia products when assessing total daily intake because the active boswellic-acid and AKBA yields may not be fully disclosed.
  • A new rash, digestive upset, or other persistent intolerance after starting Boswellia warrants stopping use and reassessing the product.

Product analysis

80 out of 100
Boswellia provides focused Boswellia support in a practical format. Total boswellic acids, AKBA, and absorption technology are not disclosed, leaving active potency uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient quality85

The focused extract supplies a practical amount without unnecessary additions. Missing active-acid standards and absorption support keep form quality ordinary.

Ingredient transparency80

The extract amount, species, and plant material are clearly disclosed without a hidden blend. Active strength, complete directions, and non-active ingredients remain missing.

Customer satisfaction65

The supplied average rating is strong and the rating volume is limited. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money89

A useful amount and long supply provide strong routine value. Incomplete potency detail is the main limitation against more transparent competitors.

Format
Capsule
Container
120 Capsule(s)
Per serving
$0.30
Customer rating
4.7 · 63 ratings
Report analysis

Goals

Joint Health
Impact
Moderate effect
A+ Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Boswellia · 400 mg
Study evidence
Boswellia Supportive 24 studies
Impact
Moderate effect
A- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Boswellia · 400 mg
Study evidence
Boswellia Supportive 19 studies

Ingredients

IngredientAmount per servingScore
Indian Frankincense Gum Resin Extract (Boswellia serrata Gum Resin Extract)
400 mg 85
Gluten Free Adults 18–50 Women
Report overview
B- Composition And Label DisclosureA+ Composition And Label Disclosure
Boswellia lists 400 mg of Boswellia serrata gum resin extract and a reported 60% boswellic-acid marker. The form, amount, and marker are disclosed, while the saved facts don't include an extract ratio. There is no price-based comparison for the Boswellia ingredient.
How this ingredient is rated

Composition and Label Disclosure70

The ingredient is identified as Boswellia serrata gum resin extract.
Marker and Preparation Disclosure
The form is clear, but no extract ratio is listed in the saved facts.

Composition and Label Disclosure100

The label includes both extract amount and boswellic-acid marker detail.
Boswellia Amount and Marker Disclosure
It lists 400 mg of extract and reports a 60% boswellic-acid marker.

Commercial Price and Usability

No price-based comparison is available for the Boswellia ingredient.
Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  2. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  3. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  4. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsJoint Health Anti-Inflammatory Support forBoswellia
  5. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  6. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  7. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  8. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support Joint Health forBoswellia
  9. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health Anti-Inflammatory Support forBoswellia
  10. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  11. Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Karlapudi V; Sunkara KB; Konda PR; Sarma KV; Rokkam MP · Journal of the American Nutrition Association · 2023
    Randomized trial70 participantsJoint Health forBoswellia
  12. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
    Zhang Y; Gui Y; Adams R; Farragher J; Itsiopoulos C; Bow K; Cai M; Han J · Nutrients · 2025
    Meta-analysis4,599 participants39 studies pooledJoint Health forBoswellia
  13. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis.
    Bannuru RR; Osani MC; Al-Eid F; Wang C · Seminars in arthritis and rheumatism · 2019
    Meta-analysis1,009 participants11 studies pooledJoint Health forBoswellia
  14. A full-spectrum Boswellia serrata extract with enhanced bioavailability, and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled, 3-arm study.
    Mamatha K; Prabhakaran P; Syam Das S; Kanjoormana Aryan M; Thomas J · Frontiers in pharmacology · 2025
    Randomized trial105 participantsAnti-Inflammatory Support forBoswellia
  15. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
    Sengupta K; Krishnaraju AV; Vishal AA; Mishra A; Trimurtulu G; Sarma KV; Raychaudhuri SK; Raychaudhuri SP · International journal of medical sciences · 2011
    Randomized trial60 participantsJoint Health forBoswellia
  16. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities.
    Efferth T; Oesch F · Seminars in cancer biology · 2022
    Systematic reviewAnti-Inflammatory Support forBoswellia
  17. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia